Investing in tomorrow's medicine

 

Mérieux Equity Partners is a global investment platform specialized in the healthcare & nutrition sector, working alongside entrepreneurs and companies with ambitious growth plan, offering them privileged access to sector-expertise and industrial network.

News

Twist Bioscience launches Long Oligos to fuel drug development, DNA data storage and gene editing research

29/07/2019

At up to 300 bases, or nucleotides, in length this is the longest commercial oligo offering by continuous chemical synthesis in the industry.

CEVA COMPLETES ACQUISITION OF IDT VETERINARY BUSINESS ASSETS, MOVING CLOSER TO ITS 2020 OBJECTIVE OF 50:50 BIO-PHARMA SPLIT

03/07/2019

Ceva and IDT have successfully completed the acquisition of IDT’s veterinary biopharmaceutical and R&D activities by Ceva.

SuperSonic Imagine announces that it has received a binding offer from the Hologic group to acquire 100% of the Company’s capital for a price of €1.50 per share

21/06/2019

Hologic is planning to acquire a controlling stake of approximately 46% of the Company’s capital.

Key figures

25
Supported Companies
21
Team
525
Assets Under Management
(€ million)
3
Offices